$SXTP 3 SEC Filings

Filed On	Filing
29 Jul 2026	Form 3: Knight Therapeutics Inc., 10% owner Holds 658,629 shares of Common Stock, $0.0001 par value per share
19 May 2026	Form 3: Francois Eric, Director No securities owned
14 Aug 2025	Form 3: Landon Kristen, Chief Operating Officer No securities owned
18 Dec 2023	Form 3: Knight Therapeutics Inc, 10% owner and 1 other Holds 1,108,337 shares of Common Stock, $0.0001 par value per share ("Common Shares")
11 Jul 2023	Form 3: Xu Cheryl, Director Holds 10,000 shares of Common Stock
11 Jul 2023	Form 3: Field Paul, Director Holds 10,000 shares of Common Stock
11 Jul 2023	Form 3: Toovey Stephen, Director Holds 10,000 shares of Common Stock
11 Jul 2023	Form 3: Allen Charles W, Director Holds 10,000 shares of Common Stock
11 Jul 2023	Form 3: Dow Geoffrey S, Director Holds 667,143 shares of Common Stock
11 Jul 2023	Form 3: Florida State University Research Foundation Inc., 10% owner Holds 405,000 shares of Common Stock
11 Jul 2023	Form 3: Kentucky Technology Inc., 10% owner Holds 525,000 shares of Common Stock
11 Jul 2023	Form 3: Miller Tyrone, Chief Financial Officer Holds 101,928 shares of Common Stock
11 Jul 2023	Form 3: Smith Bryan Lee, Chief Medical Officer No securities owned

Comments